Assessment of cardiovascular risk.
Atherosclerotic cardiovascular disease (CVD) is the most common cause of death worldwide. Usually atherosclerosis is caused by the combined effects of multiple risk factors. For this reason, most guidelines on the prevention of CVD stress the assessment of total CVD risk. The most intensive risk factor modification can then be directed towards the individuals who will derive the greatest benefit. To assist the clinician in calculating the effects of these multiple interacting risk factors, a number of risk estimation systems have been developed. This review address several issues regarding total CVD risk assessment: Why should total CVD risk be assessed? What risk estimation systems are available? How well do these systems estimate risk? What are the advantages and disadvantages of the current systems? What are the current limitations of risk estimation systems and how can they be resolved? What new developments have occurred in CVD risk estimation?
Cooney
Marie Therese
MT
Department of Cardiology, Adelaide Meath Hospital, Tallaght, Dublin, 24, Ireland. therese.cooney@yahoo.com
Cooney
Helen C
HC
Dudina
Alexandra
A
Graham
Ian M
IM
D000367:Age Factors; D050197:Atherosclerosis / Q000097:blood / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D015415:Biomarkers / Q000097:blood; D001794:Blood Pressure / Q000502:physiology; D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D002784:Cholesterol / Q000097:blood; D015897:Comorbidity; D017408:Guidelines as Topic / Q000592:standards*; D006339:Heart Rate; D006801:Humans; D018570:Risk Assessment / Q000379:methods / Q000592:standards / Q000639:trends; D012737:Sex Factors; D012907:Smoking / Q000009:adverse effects
D015415:Biomarkers; D002784:Cholesterol